ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q3Scopus Q3SCImago #8,848Review JournalHybrid

CURRENT DIABETES REVIEWS

Identifier (ISSN):1573-3998(Print)/1875-6417(Online)
•
Publisher:Bentham
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
2.6↑ +0.7
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for CURRENT DIABETES REVIEWS

WoS Q3
12453.320232.420241.920252.62026
Annual Impact Factor Metric
Current (2026):2.6
Scopus SJR & RankScopus Q3
0.66
#8,848

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
77

77 papers with at least that number of citations each

WoS: ESCIQ3
Self-Citation Rate4.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
95articles/year
7.54% Gold OA•28.41% Original Research

Aims & Scope

Current Diabetes Reviews publishes frontier reviews on all the latest advances on diabetes and its related areas e.g. pharmacology, pathogenesis, complications, epidemiology, clinical care, and therapy. The journal"s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians who are involved in the field of diabetes.

Topics Covered (Recognized by AI)
Medicine99.7%Biology96.1%Endocrinology93.8%Diabetes mellitus90.9%Internal medicine85.1%Pathology66.7%Chemistry47.2%Biochemistry45%Type 2 diabetes41.3%Biotechnology39.3%Insulin38.5%Genetics37.9%Psychology30.8%Disease27.8%Intensive care medicine27.4%Obesity27.4%Surgery24.3%Psychiatry22.6%Bioinformatics20.3%Physics20.2%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

ENDOCRINOLOGY & METABOLISM

Q3
Rank128/198
IndexESCI
JCIESCI2026

ENDOCRINOLOGY & METABOLISM

Q4
Rank156/198
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.6
Articles / Year45
Total Citations9
2025
IF1.9
Articles / Year40
Total Citations81
2024
IF2.4
Articles / Year117
Total Citations550
2023
IF3.3
Articles / Year108
Total Citations1,066
2022
IF—
Articles / Year119
Total Citations721

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,848Scopus Q3SCImago Profile
Scopus Coverage:1996, 2005-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q3
0.66

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
3.13

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,083 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,016
3-Year Documents336
Citable Documents331

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

EndocrinologyQ3
Endocrinology, Diabetes and MetabolismQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ENDOCRINOLOGY & METABOLISM
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

CURRENT DIABETES REVIEWS (ISSN: 1573-3998) is a peer-reviewed international scholarly journal in the field of ENDOCRINOLOGY & METABOLISM, published by Bentham in United Arab Emirates. The periodical holds a Journal Impact Factor (JIF) of 2.60, ranking in quartile Q3 of Web of Science (ESCI), a Scopus SJR indicator of 0.660 (Q3), an H-index of 77.

The journal enforces rigorous peer evaluation with an annual output of approximately 95 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,083 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Bentham
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 2fe8e22a-e006-431e-9510-c7ea5789ae0a
Database Updated: 2026-10-01